|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | C07D 215/38 | |
| C07D 413/12 | |||
| C07D 409/12 | |||
| C07D 401/12 | |||
| C07D 417/12 | |||
| C07D 405/12 | |||
| A61K 31/4709 |
| (11) | Patento numeris | 1876174 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07118193.7 |
| Europos patento paraiškos padavimo data | 2004-07-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2008-01-09 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2009-11-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 0316915 | 2003-07-18 | GB |
| (72) |
Bergauer, Markus, IT
Bertani, Barbara, IT
Biagetti, Matteo, IT
Bromidge, Steven, Mark, IT
Falchi, Alessandro, IT
Leslie, Colin, Philip, IT
Merlo, Giancarlo, IT
Pizzi, Domenica, Antonia, IT
Rinaldi, Marilisa, IT
Stasi, Luigi, IT
Tibasco, Jessica, IT
Vong, Antonio, Kuok, Keong, GB
Ward, Simon, Edward, GB
|
| (73) |
GLAXO GROUP LIMITED,
Glaxo Wellcome House, Berkeley Avenue,, Greenford, Middlesex UB6 0NN,
GB
|
| (54) | Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors |
| Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors |